XNAS
BIOX
Market cap20mUSD
Oct 08, Last price
0.33USD
1D
-1.88%
1Q
-4.37%
IPO
-96.60%
Name
Bioceres Crop Solutions Corp
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Bioceres Crop Solutions Corp. (BIOX) is a company dedicated to enhancing agricultural output through a diverse range of solutions. Its operations are organized into three principal divisions. The Seed and Integrated Products segment is responsible for creating and bringing to market cutting-edge seed technologies, genetic material, biotechnological innovations, and specialized seed coatings. Under its Crop Protection segment, the company formulates, manufactures, and distributes a comprehensive array of products, including Rizoderma, various adjuvants, therapeutic agents, weed killers, insect eradicators, fungal treatments, and pest lures. The Crop Nutrition unit focuses on the development, production, and distribution of inoculants, bio-stimulants, and both organic and micro-granular fertilizers. A notable offering from Bioceres is HB4, an innovative seed technology engineered for drought resistance. The enterprise maintains a significant presence across several countries, including Argentina, Uruguay, France, and South Africa, alongside broader international operations. Established in 2001, the firm's main offices are situated in Rosario, Argentina. Bioceres Crop Solutions Corp. functions as a subsidiary entity under the umbrella of Bioceres LLC.
Related entities
Parent
BIOCERES LLC
Key people
Enrique Lecube
Chief Financial Officer · since 2025
Jorge Wagner
Chief Operating Officer · since 2016
Geronimo Watson
Chief Technology Officer · since 2014
Ricardo Yapur
Managing Director of Rizobacter Argentina S.A. · since 2013
Milen Marinov
Executive Director, Chief Commercial Officer · since 2025
Federico Trucco
Chief Executive Officer, Executive Director · since 2014
Scott Crocco
Director · since 2025
Noah Kolatch
Director · since 2025
Ari Freisinger
Non-Executive Independent Director · since 2019
Kyle Bransfield
Non-Executive Independent Director · since 2019
Carlos Camargo de Colon
Non-Executive Independent Director · since 2019
Natalia Zang
Non-Executive Independent Director · since 2019
Legal address
P.O. Box 309, Ugland House
Grand Cayman E9
George Town KY1-1104
KY
Grand Cayman E9
George Town KY1-1104
KY
Headquarters
Ocampo 210 bis
Predio Conicet
Rosario, S 2000
AR
Predio Conicet
Rosario, S 2000
AR
Previous name
Union Acquisition Corp.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑06 | 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||